Overhyped Social Media Stocks Highlight Value in CrowdGather

Facebook IPO puts emphasis on social media stocks

There is a lot of activity surrounding social media stocks with the Initial Public Offering of Facebook (NASDAQ: FB) coming on Friday.  The new listing, which could see the company valued at as much as $100 billion, has investors and analysts already concerned that the world’s largest social network could be overvalued from the get-go.  Rather than try to ride that wave, savvy investors are looking to other social media and networking-related stocks that may offer a larger upside potential.  An assessment of book value to price and shareholder equity/deficit of companies s…

Apple and Hammacher Store Sales Should Boost AltiGen’s iFusion Revenue

iFusion iPhone Product Now Available at Apple Store and Hammacher Schlemmer

Sales of AltiGen Communications’ (OTCQX:ATGN) could be getting a shot in the arm for the remainder of this quarter and in upcoming quarters as their revolutionary iFusion SmartStation is now available at the Apple, Inc.’s (NASDAQ:AAPL) Apple Store (http://store.apple.com/us/product/H7939VC/A/altigen-ifusion-smartstation-dock-for-iphone) and the uber-popular Hammacher Schlemmer website (http://www.hammacher.com/Produc…

ecoTECH Energy Preps for Site Construction of Eco-Industrial Complex and Receives $55 Million Debt Financing

Company on Path to Profitability with Green Technologies

In preparation for what will be one of the most advanced complexes of its type in North America, ecoTECH Energy Group, Inc. (OTCBB:ECTH) has begun to clear the McBride, British Columbia Lamming Mills site for its Aquaponics and Combined Heat and Power (CHP) facility that is slated for construction this Spring.  The Canadian Ministry of Forests and Range has granted ecoTECH its Timber Mark Certificate and a local logging company has been contracted to selectively cut enough trees to allow room for the development, whilst retaining as many trees as possible on the site.

500 Million or 1 in 10 Adults Will Have Diabetes by 2030

International Diabetes Federation anticipates a 50 percent rise in people living with diabetes in next two decades.

The International Diabetes Federation (IDF) is the umbrella organization of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950, and IDF’s mission is to promote diabetes care, prevention, and a cure worldwide.

The “Green Revolution” Driving Investors to ecoTECH Energy

The need to cut usage of fossil fuels, so-call "brown energy," is not exactly a new concept. Over the last three decades, U.S. governments have spent roughly $40 billion promoting the use of alternative energies. Today, the "green revolution" is beginning to hit its stride through not only a global social consciousness, but also through a more legislative approach as well. The nascent mandates will have people and businesses not only be operating in a more environmentally-friendly fashion because they want to, but because they have to as a result of a political boom towards green energy.

Profire Energy (PFIE): Triple Digit Growth in the Third Quarter

Revenue and Net Income Surge

Profire Energy Inc. (OTCBB: PFIE) is an innovative provider of safe and efficient burner management systems and services for use in oilfield combustion, with customers like Devon Energy Corporation (NYSE: DVN) and EnCana Corporation (NYSE: ECA), as well as smaller “mom and pop” oil and gas exploration and development companies.

Cellceutix Files IND for New Cancer Drug Clinical Trials

Planned Clinical Trials to be Hosted by Dana-Farber and Beth Israel Deaconess Medical Center

Cellceutix Corporation (OTCBB:CTIX) ("the Company"), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat unmet medical conditions, is pleased to report that the Company has filed its Investigational New Drug (IND) application for Kevetrin™, a novel anti-cancer drug, with the U.S. Food and Drug Administration (FDA). The Company must now wait 30 calendar days before initiating the clinical trial. During this time, the FDA reviews the data in the IND and determines the conditions under which human trials can commence.

Brekford Produces Strong Numbers in Q3, Profits Up More than 100 Percent

Sales, Income, Profit and Profit Margins Climb

Brekford Corporation (OTCBB:BFDI) released financial information from its third fiscal quarter 2011 this morning.  The Hanover, Maryland-based technology service provider showed the type of growth that investors want to see with revenue climbing 100.7 percent, gross profit surging by 162.4 percent and net profit jumping upward by an alarming 1,311.7 percent.